<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | McCoy Humphries | Activity</title>
	<link>https://www.catswannabecats.com/members/jumboiran6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/jumboiran6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for McCoy Humphries.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e5a30c08c6a8ded5aa83dcaf1a85fb2f</guid>
				<title>McCoy Humphries posted an update: Core binding factor acute myelogenous leukemia (CBF-AML), [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2623/</link>
				<pubDate>Sat, 31 May 2025 08:44:49 -0400</pubDate>

									<content:encoded><![CDATA[<p>Core binding factor acute myelogenous leukemia (CBF-AML), characterized by the presence of either t(8;21) (q22;q22) or inv(16) (p13q22)/t(16;16), is considered good-risk AML in the context of cytarabine based intensive chemotherapy. Still, outcome can be improved significantly through the effective implementation of available therapeutic measures&hellip;<span class="activity-read-more" id="activity-read-more-2623"><a href="https://www.catswannabecats.com/activity/p/2623/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c80bbc61ae1cf2c4b114a81c0a224f39</guid>
				<title>McCoy Humphries posted an update: Core binding factor acute myelogenous leukemia (CBF-AML), [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2437/</link>
				<pubDate>Sat, 31 May 2025 08:17:30 -0400</pubDate>

									<content:encoded><![CDATA[<p>Core binding factor acute myelogenous leukemia (CBF-AML), characterized by the presence of either t(8;21) (q22;q22) or inv(16) (p13q22)/t(16;16), is considered good-risk AML in the context of cytarabine based intensive chemotherapy. Still, outcome can be improved significantly through the effective implementation of available therapeutic measures&hellip;<span class="activity-read-more" id="activity-read-more-2437"><a href="https://www.catswannabecats.com/activity/p/2437/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">05a11027246ae9f3b1b6a0f82e9bd03f</guid>
				<title>McCoy Humphries became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/2232/</link>
				<pubDate>Sat, 31 May 2025 08:02:19 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>